Skip to main content 2024 Spatial landscapes of cancers: insights and opportunities. Julia Chen , Ludvig Larsson, Alexander Swarbrick, Joakim Lundeberg2021 MDM2 as a Rational Target for Intervention in CDK4/6 Inhibitor Resistant, Hormone Receptor Positive Breast Cancer. Neil Portman, Julia Chen , Elgene Lim 2021 Diagnostic value of Ga-DOTATATE PET-CT imaging for staging of ER /PR HER2- breast cancer patients with metastatic disease: Comparison with conventional imaging with bone scan, diagnostic CT and F-FDG PET-CT in a prospective pilot trial. Andrew Nguyen, Karen Fullard, Gemma Sheehan-Dare, Reuben Tang, Lyn Chan, Bao Ho, Rachel Dear, Joanne Keane, Adam Hickey, Rohan Nandurkar, Julia Chen , Andrew Chen, Elgene Lim, Louise Emmett 2021 The management of HER2-positive early breast cancer: Current and future therapies. Julia Chen , Maree Colosimo, Elgene Lim2021 Case Report: Paclitaxel-Induced Pneumonitis in Early Breast Cancer: A Single Institution Experience and Review. Luke Ardolino, Brandon Lau, Isabella Wilson, Julia Chen , Linda Borella, Emily Stone, Elgene Lim 
